The debate continues about the failure of private medical schemes to cover the cost of Hepatitis B and C treatment. public sector patients can access these treatments.

Medical Schemes do not cover the treatment of some diseases, such as chronic viral hepatitis, whilst public sector patients can access these treatments. Mark Sonderup, Wendy Spearman and Nathan Geffen argue that medical schemes are not doing their share, to the detriment of patients.